Kirchhof, P., & Borggrefe, M. (2012). Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): A prospective, randomised, open-label, blinded endpoint assessment trial. The lancet, 380(9838), . https://doi.org/10.1016/S0140-6736(12)60570-4
Chicago-Zitierstil (17. Ausg.)Kirchhof, Paulus, und Martin Borggrefe. "Short-term Versus Long-term Antiarrhythmic Drug Treatment After Cardioversion of Atrial Fibrillation (Flec-SL): A Prospective, Randomised, Open-label, Blinded Endpoint Assessment Trial." The Lancet 380, no. 9838 (2012). https://doi.org/10.1016/S0140-6736(12)60570-4.
MLA-Zitierstil (9. Ausg.)Kirchhof, Paulus, und Martin Borggrefe. "Short-term Versus Long-term Antiarrhythmic Drug Treatment After Cardioversion of Atrial Fibrillation (Flec-SL): A Prospective, Randomised, Open-label, Blinded Endpoint Assessment Trial." The Lancet, vol. 380, no. 9838, 2012, https://doi.org/10.1016/S0140-6736(12)60570-4.